InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Berrey M Michelle, Président de la R&D. Officer active across 1 company, notably Intercept Pharmaceuticals, INC.. Cumulatively, 11 disclosures have been published. Activity tracked since 14 June 2021. The latest transaction was filed on 8 November 2023 (U). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Berrey M Michelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
28,349 shares@ US$19.0076.9% of flowCommon StockSEC:0001104659-23-117115:0
1,246 shares@ US$11.572.1% of flowCommon StockSEC:0001104659-23-101573:0
1,246 shares@ US$12.042.1% of flowCommon StockSEC:0001104659-23-072210:0
1,246 shares@ US$15.792.8% of flowCommon StockSEC:0001104659-23-033307:0
14,700 shares0Common StockSEC:0001104659-23-008581:0
765 shares@ US$12.371.4% of flowCommon StockSEC:0001104659-23-000327:0
1,246 shares@ US$14.942.7% of flowCommon StockSEC:0001104659-22-127799:0
1,246 shares@ US$17.143.3% of flowCommon StockSEC:0001104659-22-100803:0
4,984 shares@ US$12.10100.0% of flowCommon StockSEC:0001104659-22-071868:0
10,300 shares0Common StockSEC:0001104659-22-009551:0
67,118 shares0Common StockSEC:0001104659-21-081624:0
11 of 11 declarations
About Berrey M Michelle
Berrey M Michelle is Président de la R&D at Intercept Pharmaceuticals, INC. on XNAS. She has 11 filings in total, and the sampled filings run from 2021-06-15 to 2023-11-13, with transactions described as tax withholding.
